Showing results (311-320 of 441) with videos related to
Sort By:
Pageof 45
Neuro-Oncology|March 4, 2008
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiformeVinay K Puduvalli, Pierre Giglio, Morris D Groves, et al.Neuro-Oncology Advances|February 4, 2025
cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnosticsKenneth Aldape, David Capper, Andreas von Deimling, et al.Acta Neuropathologica|February 11, 2012
A prognostic gene expression signature in infratentorial ependymomaKhalida Wani, Terri S Armstrong, Elizabeth Vera-Bolanos, et al.Journal of Neuro-Oncology|October 29, 2015
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group studyH Ian Robins, Peixin Zhang, Mark R Gilbert, et al.Molecular Cancer Research : MCR|September 15, 2021
Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma ModelAmélie Vézina, Monica Manglani, DreeAnna Morris, et al.Neuro-Oncology|August 15, 2014
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patientsElizabeth Vera-Bolanos, Kenneth Aldape, Ying Yuan, et al.Neuro-Oncology Advances|February 26, 2024
Unsupervised machine learning models reveal predictive clinical markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiationWesley Wang, Zeynep Temerit Kumm, Cindy Ho, et al.The Journal of Pathology|April 29, 2018
Enhancement of mitochondrial biogenesis and paradoxical inhibition of lactate dehydrogenase mediated by 14-3-3η in oncocytomasJie Feng, Qi Zhang, Chuzhong Li, et al.Neuro-Oncology Advances|May 11, 2022
Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT)Heather E Leeper, Emily Tonorezos, Deborah Mayer, et al.Cancers|December 10, 2021
Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse GliomasGuangyang Yu, Ying Pang, Mythili Merchant, et al.Pageof 45